NO933918L - 2- og 5-alkyl-og fenylsubstituerte 4- (1-hydroksy-, 1-acyloksy- e ller 1- karbamoyloksy)-5-hydroksy-2(5H)- furanoner som anti-inflammatorisk e midler - Google Patents
2- og 5-alkyl-og fenylsubstituerte 4- (1-hydroksy-, 1-acyloksy- e ller 1- karbamoyloksy)-5-hydroksy-2(5H)- furanoner som anti-inflammatorisk e midlerInfo
- Publication number
- NO933918L NO933918L NO933918A NO933918A NO933918L NO 933918 L NO933918 L NO 933918L NO 933918 A NO933918 A NO 933918A NO 933918 A NO933918 A NO 933918A NO 933918 L NO933918 L NO 933918L
- Authority
- NO
- Norway
- Prior art keywords
- alkyl
- phenyl
- hydroxy
- substituted phenyl
- carbons
- Prior art date
Links
- 229940121363 anti-inflammatory agent Drugs 0.000 title 1
- 239000002260 anti-inflammatory agent Substances 0.000 title 1
- VIHAEDVKXSOUAT-UHFFFAOYSA-N but-2-en-4-olide Chemical class O=C1OCC=C1 VIHAEDVKXSOUAT-UHFFFAOYSA-N 0.000 title 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 15
- 125000000217 alkyl group Chemical group 0.000 abstract 6
- 229910052736 halogen Inorganic materials 0.000 abstract 6
- 125000005843 halogen group Chemical group 0.000 abstract 6
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 5
- 125000001624 naphthyl group Chemical group 0.000 abstract 3
- 125000003837 (C1-C20) alkyl group Chemical group 0.000 abstract 1
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 1
- RHDGNLCLDBVESU-UHFFFAOYSA-N but-3-en-4-olide Chemical group O=C1CC=CO1 RHDGNLCLDBVESU-UHFFFAOYSA-N 0.000 abstract 1
- 150000002241 furanones Chemical class 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/60—Two oxygen atoms, e.g. succinic anhydride
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/0803—Compounds with Si-C or Si-Si linkages
- C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
- C07F7/0812—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
- C07F7/0814—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring said ring is substituted at a C ring atom by Si
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
- C07F9/65515—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pain & Pain Management (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Rheumatology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Furan Compounds (AREA)
Abstract
Nye anti-inflammatoriske furanonforbindelser har følgende formel hvor R1 uavhengig er H, fenyl, C^-Ctalkylsubstituert fenyl, halogensubstituert fenyl, eller alkyl med l til 6 karbon- atomer, og n er et helt tall med verdier på l eller 2, og hvor når n er l, er Ri-gruppen bundet enten til 3- eller 5-still- ingen i 2-furanonet, når n er 2, er Rj. bundet til både 3- og 5- stillingen, under den forutsetning at når n er l, er R! ikke H; Y! er H, alkyl med l til 20 karbonatomer, fenyl-Ci-C^alkyl, C±- C20alkenyl inneholdende en eller flere olefinbindinger, PO(OH)2, PO(OH)OR2, PO(OH)R2, PO(OR2)2, hvor R2 uavhengig er alkyl med l til 20 karbonatomer, fenyl, eller halogensubsti- tuert fenyl eller Ci-Cjalkylsubstituert fenyl, YL videre er CO- R3, CO-OR3, CONHR3, S02R3, S02NHR3, (CH2)p-O-R3, eller (CH2)p-O- (CH2)m-0-R3, hvor p og m er hele tall og uavhengig er l til 20, og R3 er H, Cj_-C20alkyl, Ci-Czoalkenyl inneholdende en eller flere olefinbindinger, fenyl, halogensubstituert fenyl eller Ci-C6alkylsubstituert fenyl, under den forutsetning at når Y! er CO-R3, CO-ORj og CONHR3, er R3 ikke hydrogen; Y2 er H, en alkylgruppe med l til 25 karbonatomer, fenyl, naftyl, fenyl(CL C20)alkyl-, naftyl (C^-CZQ) alkyl-, halogensubstituert fenyl, G!~ C6akyl-substituert fenyl, halogensubstituert naftyl, C^-CjSub- stituert naftyl; Y3 er H, alkyl med l til 20 karbonatomer, CO- Rt, CO-0-R4, CO-NH-RA, PO(ORJZ eller PO(ORJR4, hvor R4 uavhen- gig er H, alkyl med l til 20 karbonatomer, fenyl eller halo- gensubstituert fenyl eller Ci-Cealkylsubstituert fenyl.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/693,204 US5183906A (en) | 1991-04-30 | 1991-04-30 | 2- and 5-alkyl and phenyl substituted 4-(1-hydroxy, 1-acyloxy or 1-carbamoyloxy)-5-hydroxy-2 (5h)-furanones as anti-inflammatory agents |
PCT/US1992/003623 WO1992019610A1 (en) | 1991-04-30 | 1992-04-29 | 2- and 5-alkyl and phenyl substituted 4-(1-hydroxy, 1-acyloxy or 1-carbamoyloxy)-5-hydroxy-2(5h)-furanones as anti-inflammatory agents |
Publications (2)
Publication Number | Publication Date |
---|---|
NO933918D0 NO933918D0 (no) | 1993-10-29 |
NO933918L true NO933918L (no) | 1993-12-28 |
Family
ID=24783742
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO933918A NO933918L (no) | 1991-04-30 | 1993-10-29 | 2- og 5-alkyl-og fenylsubstituerte 4- (1-hydroksy-, 1-acyloksy- e ller 1- karbamoyloksy)-5-hydroksy-2(5H)- furanoner som anti-inflammatorisk e midler |
Country Status (10)
Country | Link |
---|---|
US (1) | US5183906A (no) |
EP (1) | EP0579769B1 (no) |
JP (1) | JP3181054B2 (no) |
AT (1) | ATE172459T1 (no) |
AU (1) | AU1923892A (no) |
CA (1) | CA2109064A1 (no) |
DE (1) | DE69227366T2 (no) |
ES (1) | ES2124261T3 (no) |
NO (1) | NO933918L (no) |
WO (1) | WO1992019610A1 (no) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5268387A (en) * | 1992-04-24 | 1993-12-07 | Allergan, Inc. | Pharmaceutical compositions and method for administering 3 and 4-substituted 2(5H)-furanones to a mammal for inhibiting bone loss |
WO1994026279A1 (en) * | 1993-05-18 | 1994-11-24 | The Upjohn Company | Bisphosphonate esters for treating gastric disorders |
EP0714391A1 (en) * | 1993-08-19 | 1996-06-05 | Warner-Lambert Company | Substituted 2(5h)furanone, 2(5h)thiophenone and 2(5h)pyrrolone derivatives, their preparation and their use as endothelin antagonists |
US5464865A (en) * | 1993-12-22 | 1995-11-07 | Ortho Pharmaceutical Corporation | 4-aryl- and 4-arylthio-5-hydroxy-2(5H)-furanones as inhibitors of phospholipase A2 |
US5451686A (en) * | 1994-04-15 | 1995-09-19 | Allergan, Inc. | 3 and 5 alkyl and phenyl 4-(hydroxy or acyloxy)-alkyl substituted 2(5H)-furanones as anti-inflammatory agents |
US5639468A (en) * | 1995-06-07 | 1997-06-17 | University Of Southern California | Method for reducing or preventing post-surgical adhesion formation using manoalide and analogs thereof |
US5922759A (en) * | 1996-06-21 | 1999-07-13 | Warner-Lambert Company | Butenolide endothelin antagonists |
US5998468A (en) * | 1995-08-24 | 1999-12-07 | Warner-Lambert Company | Furanone endothelin antagonists |
US5891892A (en) * | 1996-10-29 | 1999-04-06 | Warner-Lambert Company | Small molecule biaryl compounds as inhibitors of endothelin converting enzyme |
ATE445838T1 (de) | 2001-07-25 | 2009-10-15 | Raptor Pharmaceutical Inc | Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke |
CA2571710A1 (en) | 2004-06-24 | 2006-11-02 | Nicholas Valiante | Small molecule immunopotentiators and assays for their detection |
DK1889198T3 (da) | 2005-04-28 | 2015-02-09 | Proteus Digital Health Inc | Farma-informatiksystem |
WO2008036682A2 (en) | 2006-09-18 | 2008-03-27 | Raptor Pharmaceutical Inc. | Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates |
ES2728225T3 (es) | 2009-02-20 | 2019-10-23 | 2 Bbb Medicines B V | Sistema de administración de fármacos a base de glutatión |
US8445002B2 (en) | 2009-05-06 | 2013-05-21 | Laboratory Skin Care, Inc. | Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same |
US20120077778A1 (en) | 2010-09-29 | 2012-03-29 | Andrea Bourdelais | Ladder-Frame Polyether Conjugates |
FR2978963A1 (fr) | 2011-08-11 | 2013-02-15 | Ascorbix | Nouveaux derives des furanones et composition pharmaceutique les contenant |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2359096A (en) * | 1941-03-21 | 1944-09-26 | Lilly Co Eli | beta-substituted-delta alpha, beta-gamma-butyrolactones and beta-substituted - beta - hydroxy-gamma-butyrolactones and methods of preparing them |
US2359208A (en) * | 1941-03-21 | 1944-09-26 | Lilly Co Eli | beta-substituted-delta alpha,beta-gamma-butyrolactones and beta-substituted-beta-hydroxy-gamma-butyrolactones and the methods of preparing them |
EP0133376B1 (en) * | 1983-08-03 | 1988-07-27 | The Regents Of The University Of California | Synthetic analgesic and/or anti-inflammatory derivatives of manoalide |
US4447445A (en) * | 1983-08-03 | 1984-05-08 | The Regents Of The University Of Calif. | Manoalide, an anti-inflammatory analgesic marine natural product |
US4789749A (en) * | 1984-06-18 | 1988-12-06 | The Regents Of The University Of California | Manoalide analogs |
ZA864674B (en) * | 1985-07-01 | 1988-02-24 | Lilly Co Eli | Furanone derivatives |
US4874782A (en) * | 1985-07-01 | 1989-10-17 | Eli Lilly And Company | Furanone derivatives |
US4786651A (en) * | 1986-02-03 | 1988-11-22 | Allergan, Inc. | Treatment of cutaneous hyperproliferative dermatoses with manoalide |
DE3615157A1 (de) * | 1986-05-05 | 1987-11-12 | Schwabe Willmar Gmbh & Co | 5-arylalkyl-4-alkoxy-2(5h)-furanone, zwischenprodukte und verfahren zu ihrer herstellung sowie ihre anwendung als therapeutische wirkstoffe |
US5037811A (en) * | 1990-04-17 | 1991-08-06 | Allergan, Inc. | 4-(oxygen, sulfur or nitrogen substituted)-methyl 5-hydroxy-2(5H)-furanones as anti-inflammatory agents |
US5043457A (en) * | 1990-04-17 | 1991-08-27 | Allergan, Inc. | 2(5H)-furanones substituted in the 3 position, as Ca2+ channel antagonists and anti-inflammatory agents |
CA1329390C (en) * | 1987-06-08 | 1994-05-10 | John N. Bonfiglio | Anti-inflammatory furanones |
US5089485A (en) * | 1988-11-18 | 1992-02-18 | Allergan, Inc. | Anti-inflammatory furanones |
US5059611A (en) * | 1988-11-18 | 1991-10-22 | Allergan, Inc. | Anti-inflammatory 5-hydroxy-2-furanones |
US4916241A (en) * | 1988-06-06 | 1990-04-10 | American Home Products Corporation | Inhibition of bone loss by 4-substituted-5-hydroxy-2(5H)-furanones |
JPH0222271A (ja) * | 1988-07-11 | 1990-01-25 | Kuraray Co Ltd | 共役γ−オキシブテノライド化合物およびこれを有効成分とする抗潰瘍剤 |
US4935530A (en) * | 1988-10-18 | 1990-06-19 | Allergan, Inc. | Process for preparing 5-substituted-3-furaldehydes |
EP0369813A3 (en) * | 1988-11-18 | 1991-02-27 | Allergan, Inc | Anti-inflammatory furanones |
US5045564A (en) * | 1988-12-07 | 1991-09-03 | Allergan, Inc. | Anti-inflammatory 2-furanones |
JPH0356472A (ja) * | 1988-12-07 | 1991-03-12 | Allergan Inc | 抗炎症5―ヒドロキシ―2―フラノンおよびその用途 |
US5013850A (en) * | 1990-03-30 | 1991-05-07 | Allergan, Inc. | 4-ethyl and 4-ethenyl-5-hydroxy-2(5H)-furanones substituted on alpha carbon of the ethyl or ethenyl side chain with a long chain alkyl group and on the beta carbon with a polar group, as anti-inflammatory agents |
-
1991
- 1991-04-30 US US07/693,204 patent/US5183906A/en not_active Expired - Lifetime
-
1992
- 1992-04-29 DE DE69227366T patent/DE69227366T2/de not_active Expired - Fee Related
- 1992-04-29 JP JP51148292A patent/JP3181054B2/ja not_active Expired - Fee Related
- 1992-04-29 ES ES92911576T patent/ES2124261T3/es not_active Expired - Lifetime
- 1992-04-29 EP EP92911576A patent/EP0579769B1/en not_active Expired - Lifetime
- 1992-04-29 WO PCT/US1992/003623 patent/WO1992019610A1/en active IP Right Grant
- 1992-04-29 AU AU19238/92A patent/AU1923892A/en not_active Abandoned
- 1992-04-29 AT AT92911576T patent/ATE172459T1/de not_active IP Right Cessation
- 1992-04-29 CA CA002109064A patent/CA2109064A1/en not_active Abandoned
-
1993
- 1993-10-29 NO NO933918A patent/NO933918L/no unknown
Also Published As
Publication number | Publication date |
---|---|
WO1992019610A1 (en) | 1992-11-12 |
JPH06507171A (ja) | 1994-08-11 |
JP3181054B2 (ja) | 2001-07-03 |
EP0579769A1 (en) | 1994-01-26 |
ATE172459T1 (de) | 1998-11-15 |
CA2109064A1 (en) | 1992-10-31 |
DE69227366T2 (de) | 1999-06-10 |
NO933918D0 (no) | 1993-10-29 |
ES2124261T3 (es) | 1999-02-01 |
DE69227366D1 (de) | 1998-11-26 |
EP0579769B1 (en) | 1998-10-21 |
AU1923892A (en) | 1992-12-21 |
US5183906A (en) | 1993-02-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO933918L (no) | 2- og 5-alkyl-og fenylsubstituerte 4- (1-hydroksy-, 1-acyloksy- e ller 1- karbamoyloksy)-5-hydroksy-2(5H)- furanoner som anti-inflammatorisk e midler | |
AU653057B2 (en) | Cosmetic composition | |
AU585452B2 (en) | Oxiranes | |
ES527954A1 (es) | Un procedimiento para preparar isoxazoles | |
BR8707408A (pt) | Novos 5-alcoxi-2,4-diamino-alquibenzenos e composicoes de tingimento de cabelo com 5-alcoxi-2,4-diamino-alquil-benzenos | |
DE69725708D1 (de) | Neue poly(monoperoxycarbanate) | |
ATE165972T1 (de) | 2(5h)- in position 3-substituierte furanone als ca 2+ antagonisten und entzündungshemmende mittel | |
AU539290B2 (en) | Stabilized peroxygenated compounds | |
KR890014443A (ko) | 신규한 치환 나프타렌 화합물 및 동 화합물을 함유하는 액정조성물 | |
DK0460488T3 (da) | Svovlholdige heterocykliske forbindelser | |
ES2074828T3 (es) | Copoliester degradable de 4-hidroxi-prolina y composicion farmaceutica que lo contiene. | |
MX170732B (es) | Composicion de derivados de succinimida y su uso | |
FI892681A0 (fi) | Nya jodade icke-joniska trijodbenzenfoereningar och dessa innehaollande kontrastmedel. | |
AU552310B2 (en) | 4-aroylimidazolin-2-ones | |
GB2020656A (en) | Tricyclo- alpha , beta -unsaturated ketones | |
FI812777L (fi) | Foerfarande foer framstaellning av nya cardenolid-bis-digitoxosider | |
ES8705426A1 (es) | Un procedimiento para la preparacion de un derivado de piperazina. | |
ATE42957T1 (de) | Waessrige kristallsuspension von steroidglykoestern. | |
AU550155B2 (en) | 3-oxabicyclo(3.1.0)hexan-2-ones | |
KR920002755A (ko) | 안정화된 과탄산나트륨 조성물 | |
FI865121A (fi) | Foerfarande foer genomfoerande av magnetiska kretsar foer stabiliseringsspolar till anvaendning i en kombination av lampor med olika urladdning. | |
KR830000766A (ko) | 폴리글리콜 에테르를 함유한 섬유조제물 | |
DE68911893D1 (de) | Antagonisten von Leukotrien D4. | |
KR830003879A (ko) | 제초제 조성물 |